Journal article
Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study
The Gambian PCV programme reduced the incidence of invasive pneumococcal disease in children aged 2–59 months by around 55%. Further surveillance is needed to ascertain the maximum effect of the vaccine in the 2–4 years and older age groups, and to monitor serotype replacement. Low-income and middle-income countries that introduce PCV13 can expect substantial reductions in invasive pneumococcal disease.
Authors
- Ahmad Manjang
- Aliu Akano
- Augustin E. Fombah
- Bade Abatan
- Bankole Kuti
- Bernard Ebruke
- Bilquees S. Muhammad
- Brian M Greenwood
- David Ameh
- David J. Jeffries
- Debasish Saha
- E. David Nsekpong
- Edward Green
- Effua Usuf
- Emmanuel Olutunde
- Grant A. Mackenzie
- Henry Badji
- Ian Plumb
- Ilias Hossain
- Jayani Pathirana
- Kim Mulholland
- Lamin Ceesay
- Malick Ndiaye
- Maria Knoll
- Martin Antonio
- Momodou Jasseh
- Ogochukwu Ofordile
- Orin S. Levine
- Oyedeji Adeyemi
- Peter Githua
- Philip C. Hill
- Rasheed Salaudeen
- Readon C. Ideh
- Richard A Adegbola
- Sana Sambou
- Sheikh Jarju
- Stephen R. Howie
- Tumani Corrah
- Uchendu Uchendu
- Usman N. A. Ikumapayi
- Yamundow Lowe-Jallow
- Yekini Olatunji
Languages
- English
Journal
The Lancet Infectious Diseases
Volume
Online First
Type
Journal article
Categories
- Service delivery